FINWIRES · TerminalLIVE
FINWIRES

Cameco's Q1 Adjusted Net Earnings More Than Double YoY

By

-- Cameco (CCO.TO) reported that its first-quarter adjusted net earnings more than doubled year over year on higher sales volumes and improved average realized price of uranium.

Adjusted net earnings were C$203 million, or $0.47 per share, rising from $70 million, or $0.16 per share. The result beat the non-GAAP earnings per share consensus estimate of $0.34 as compiled by FactSet.

Revenue was $845 million, up from $789 million. The result exceeded the sales consensus estimate of $833 million as compiled by FactSet.

Adjusted EBITDA was $509 million, an increase from $353 million.

Uranium production was 6.2 million pounds, up from 6.0 million lb. Uranium sales were 7.8 million lb at an average realized price of $91.26/lb, up from 6.9 million lb at an average realized price of $89.12/lb.

The company maintained its 2026 guidance and said nuclear energy is on track for long-term growth in support of global demand.

Related Articles

Asia

Sunita Tools' US Unit Sets Up Office in Chicago

Sunita Tools' (BOM:544001) U.S.-based subsidiary Sunita Defence Inc. has established a full-time office in Chicago, according to an Indian bourse filing on Tuesday.The subsidiary was created to bid for and supply defense products in the U.S. market and explore acquisition opportunities in the defense, aerospace and engineering space.

$BOM:544001
Asia

Zuoli Kechuang Micro-finance Changes Name to Zuoli Kechuang

Zuoli Kechuang Micro-finance Company changed its English name to Zuoli Kechuang Company Limited (HKG:6866), alongside a change in its Chinese name, according to a Tuesday Hong Kong bourse filing.The name change came about following the relevant regulatory and shareholder approvals.The financial services company's English stock short name will be changed to ZUOLI KECHUANG from ZUOLI M-FIN effective 9:00 am on May 8.

$HKG:6866
Research

Research Alert: Adm: Solid Q1 Results; Guidance Raised As Expected On Biofuel Policy Clarity

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:Archer-Daniels-Midland (ADM) delivered solid Q1 2026 results, with adjusted EPS of $0.71 (+1% Y/Y) beating consensus by $0.05. The company raised full-year 2026 guidance to $4.15-$4.70 (consensus: $4.23) from $3.60-$4.25, supported by the March 2026 Renewable Fuel Standard finalization, which provides crucial policy clarity. This regulatory certainty supports the biofuels sector and strengthens ADM's investment thesis. Carbohydrate Solutions was the standout performer, with operating profit surging 48% to $356M as ethanol operations capitalized on strengthening margins from the improved policy environment. While AS&O faced headwinds with operating profit declining 34% to $273M due to mark-to-market impacts, its underlying operational performance showed resilience. The Nutrition segment continued its recovery trajectory with 42% growth in operating profit to $135M. We believe the combination of regulatory clarity and strong operational execution positions ADM well for improved earnings performance through 2026.

$ADM